Results 201 to 210 of about 139,309 (247)

Synthetic MRI from radiotherapy planning CT images for Head‐and‐Neck Cancer

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Abstract Background Computed Tomography (CT) provides geometric accuracy and electron density information essential for radiotherapy planning; however, it offers limited soft‐tissue contrast. Magnetic Resonance Imaging (MRI) improves tumor visualization but introduces registration uncertainties when acquired separately from the radiotherapy planning CT
Prabhakar Ramachandran   +5 more
wiley   +1 more source

The Historical Evolution of Head and Neck Tumor Pathology in WHO Classifications: From Morphology to Molecular Taxonomy. [PDF]

open access: yesHead Neck Pathol
Mariano FV   +10 more
europepmc   +1 more source

Proton arc therapy reduces the dose delivered to circulating blood compared to intensity‐modulated proton therapy for head‐and‐neck cancer

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 11, November 2026.
Background Compared to intensity‐modulated proton therapy (IMPT), proton arc therapy (PAT) has various dosimetric advantages. However, questions have been raised over whether the larger low‐dose bath during PAT may increase radiation‐induced lymphocyte killing, which is correlated with adverse clinical outcomes.
Sebastian Tattenberg   +4 more
wiley   +1 more source

HPV genotyping in head and neck cancer: Insights from a Colombian cohort. [PDF]

open access: yesBraz J Otorhinolaryngol
Cruz-Romero SD   +7 more
europepmc   +1 more source

MGP_HNSC32: A H&E Morphology‐Derived 32‐Gene Prognostic Signature in Head and Neck Squamous Cell Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Head and neck squamous cell carcinoma (HNSC) exhibits substantial molecular and morphological heterogeneity, yet current morphology‐based prognostic models often lack biological interpretability. We developed a transformer‐based computational framework (CTransPath) to virtually predict gene expression directly from hematoxylin and eosin (H&E ...
Di Zhao   +5 more
wiley   +1 more source

Burden of HPV-associated cancers in Peruvian men: Evidence from national health data. [PDF]

open access: yesHum Vaccin Immunother
Otoya I   +6 more
europepmc   +1 more source

Longitudinal Swallowing and Salivary Changes With CLR 131 and Re‐Irradiation in Recurrent Head and Neck Cancer

open access: yesHead &Neck, Volume 48, Issue 11, Page 3032-3042, November 2026.
ABSTRACT Background Patients with recurrent head and neck cancer (HNC) often present with severe, persistent dysphagia and xerostomia following prior chemoradiation. Although swallowing impairments and salivary dysfunction have been reported in this population, prior longitudinal studies have not examined changes in salivary composition or how these ...
Jenni Wu   +8 more
wiley   +1 more source

“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer

open access: yesHead &Neck, Volume 48, Issue 11, Page 2977-2994, November 2026.
ABSTRACT Background Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.
Corey Patterson   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy